ASCO 26: Three cancer survivors share lessons for the field
In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.
Newsletters and Deep Dive digital magazine
In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.
Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.
Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.
The infrastructure is largely in place.
Editor's Picks
Newsletters and Deep Dive
digital magazine